OxyPrem

company

About

OxyPrem is an advanced oxygen sensor that continuously monitors oxygen levels in the brains of high-risk preterm infants.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
Fr2.20M
Industries
Health Care,Health Diagnostics,Medical Device,Nanotechnology
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

OxyPrem is an advanced oxygen sensor that continuously monitors oxygen levels in the brains of high-risk preterm infants. The company develops, designs, and manufactures sensor solutions for monitoring of preterm infants. It is a reusable device that offers better clinical care due to its high quality, while substantially reducing waste.

OxyPrem uses harmless light (more on NIRS) to determine absolute hemoglobin oxygen saturation in any human tissue. It helps them to prevent early death and severe long-term brain damage to this most vulnerable group of patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Fr2.20M
OxyPrem has raised a total of Fr2.20M in funding over 2 rounds. Their latest funding was raised on Mar 29, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 29, 2022 Grant Fr2.20M 1 European Innovation Council Detail

Investors

Number of Lead Investors
Number of Investors
1
1
OxyPrem is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant